相关实验视频

Updated: Sep 20, 2025

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

Published on: June 12, 2013

大细胞两极分化,炎症单细胞和受损的MDSC与小鼠和人类的免疫无塑性贫血有关

Joshua Glass^1,2, Xingmin Feng², Jichun Chen²

¹Cancer and Blood Disorders Center, Children's National Hospital, 111 Michigan Ave NW, Washington, DC 20010, United States.

Journal of leukocyte biology

|May 24, 2025

概括

向骨髓细胞,特别是M1巨细胞和骨髓衍生抑制细胞 (MDSC),可能为免疫介导的骨髓衰竭 (BMF) 和无塑性贫血 (AA) 提供新的治疗策略.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
在瘤学瘤学.

背景情况:

免疫媒介性骨髓衰竭 (BMF),包括无塑性贫血 (AA),涉及复杂的免疫环境.
骨髓状细胞,如单细胞,巨细胞和骨髓状细胞衍生抑制细胞 (MDSCs),在BMF病原发生中发挥作用.

研究的目的:

用小鼠模型研究CSF-1R抑制对BMF免疫病理生理学的影响.
探索潜在的治疗策略,针对免疫介导的BMF中的髓状细胞群.

主要方法:

利用BMF的小鼠模型来评估血液形成,免疫细胞种群和基因表达.
采用流细胞计,细胞因子分析和单细胞RNA测序.
使用CSF-1R抑制剂PLX3397和JAK抑制剂巴里西提尼布.

主要成果:

抑制CSF-1R会恶化BMF,增加炎症,并促进M1巨细胞的两极分化,导致生存率降低.
巴里西替尼治疗减弱了BMF,诱导了M2巨分化,并减少了CD8+ T细胞透.
单细胞RNA分析显示,在小鼠BMF和人类AA样本中,M1基因上调,在严重AA患者中具有M1样单细胞表型.

结论:

M1巨细胞和缺陷的骨髓衍生抑制细胞 (MDSC) 功能有助于免疫介导的BMF的致病和进展.
向巨细胞极化或MDSCs为BMF和无塑性贫血提供了有希望的替代治疗途径.

关键词:

在MDSCs中.没有无形性贫血.骨髓功能衰竭骨髓功能衰竭巨细胞是什么?巨细胞是什么?单细胞 (Monocytes) 是一种单细胞.

更多相关视频

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...